Thus, adiponectin mediates protective effects in obesity-related metabolic and vascular disease presumably by its anti-inflammatory actions and protects the heart against ischemia-reperfusion injury through its ability to suppress myocardial inflammation and apoptosis [23]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.